NAYAN THERAPEUTICS, INC.

Profile

Company Names

NAYAN THERAPEUTICS, INC.

Addresses

266 MAIN STREET BUILDING 2 SUITE 11, MEDFIELD, MA 02052

Phone Numbers

6177782572

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$3,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-02-04 
$3,000,000.00 
$25,000,000.00 
$22,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MILIND 
 
DESHPANDE 
EXECUTIVE OFFICER, DIRECTOR
SPERO THERAPEUTICS, LLC   |  NAYAN THERAPEUTICS, INC.   |  SANTI THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  SPERO THERAPEUTICS, INC.   |  TRIANA BIOMEDICINES, INC.
ROBERT 
 
MILLMAN 
DIRECTOR, PROMOTER
COSTIM PHARMACEUTICALS INC.   |  SEMMA THERAPEUTICS, INC.   |  ABCURO, INC.   |  NAYAN THERAPEUTICS, INC.
DAVID 
 
NEAFUS 
EXECUTIVE OFFICER
SUSTAINX INC   |  AFFERENT PHARMACEUTICALS, INC.   |  PANGENX, INC.   |  MICROCHIPS BIOTECH, INC.   |  SYNDEVRX INC   |  ARRAKIS THERAPEUTICS, INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  NAYAN THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  KERA THERAPEUTICS, INC.   |  SIGHTSTREAM BIOTHERAPEUTICS, INC.
JOSHUA 
 
RESNICK 
DIRECTOR
JERICHO CAPITAL PARTNERS, L.P.   |  COAXIA INC   |  JERICHO CAPITAL INTERNATIONAL LTD.   |  LIVESTREAM, LLC   |  JERICHO CAPITAL PARTNERS L.P.   |  SUGARFINA, LLC   |  RANA THERAPEUTICS, LLC   |  MIRAGEN THERAPEUTICS, INC.   |  JERICHO CAPITAL SPECIAL OPPORTUNITIES LTD   |  AVROBIO, INC.   |  SUGARFINA, INC.   |  RIBOMETRIX, INC.   |  NAYAN THERAPEUTICS, INC.   |  JERICHO ASIA OPPORTUNITIES LTD.   |  ATHENEN THERAPEUTICS, INC.   |  ARCUATE THERAPEUTICS, INC.   |  AEROVATE THERAPEUTICS, INC.   |  SANTI THERAPEUTICS, INC.   |  VOR BIOPHARMA INC.   |  AVILAR THERAPEUTICS, INC.   |  PEPGEN INC.   |  TRIANA BIOMEDICINES, INC.   |  ALIADA THERAPEUTICS, INC.   |  OPENSKY VENTURES FUND I, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-02-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#